Report in The Journal of Molecular Diagnostics describes a more sensitive and personalized method of identifying patients likely to relapse compared to the current gold standard.
http://www.eurekaler...s-nad020316.php
New assay detects persistent disease in leukemia patients thought to be in remission
Started by
gerry
, Feb 08 2016 05:59 PM
No replies to this topic
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users
